BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36644541)

  • 21. Aptamer-labeled PLGA nanoparticles for targeting cancer cells.
    Aravind A; Varghese SH; Veeranarayanan S; Mathew A; Nagaoka Y; Iwai S; Fukuda T; Hasumura T; Yoshida Y; Maekawa T; Kumar DS
    Cancer Nanotechnol; 2012; 3(1-6):1-12. PubMed ID: 26069492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimuli-responsive magnetic silica-poly-lactic-co-glycolic acid hybrid nanoparticles for targeted cancer chemo-immunotherapy.
    Gupta A; Niveria K; Chandpa HH; Singh M; Kumar V; Panda AK; Meena J
    Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38347431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
    Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
    J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.
    Leiva MC; Ortiz R; Contreras-Cáceres R; Perazzoli G; Mayevych I; López-Romero JM; Sarabia F; Baeyens JM; Melguizo C; Prados J
    Sci Rep; 2017 Oct; 7(1):13506. PubMed ID: 29044153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
    Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Inhibitory Effects of Paclitaxel and Vitamin D
    Khodaverdi S; Jafari A; Movahedzadeh F; Madani F; Yousefi Avarvand A; Falahatkar S
    Adv Pharm Bull; 2020 Jan; 10(1):30-38. PubMed ID: 32002359
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization and Evaluation of Poly(lactide-
    Haider M; Elsherbeny A; Jagal J; Hubatová-Vacková A; Saad Ahmed I
    Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32872639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
    Maleki H; Hosseini Najafabadi MR; Webster TJ; Hadjighassem MR; Sadroddiny E; Ghanbari H; Khosravani M; Adabi M
    Int J Pharm; 2021 Jul; 604():120722. PubMed ID: 34022255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.
    Houdaihed L; Evans JC; Allen C
    Mol Pharm; 2018 Sep; 15(9):3672-3681. PubMed ID: 29863881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation of paclitaxel-loaded and folic acid-modified poly (lactic-co-glycolic acid) nano-micelles and in vitro anticancer effect on cervical cancer HeLa cells].
    Li XJ; You Y; Zhang QL; Zhang BB; Yan L; Ou ZM; Zhang Y; Wang YJ; Tong Y; Liu DW; Wang JY
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2481-2488. PubMed ID: 34047094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.